To view this email as a web page, click here.

 
Clinical Considerations for Derm NPs and PAs
image description here This month’s highlights center on advances in treating children with skin diseases, whether lab monitoring in isotretinoin patients is still necessary, and the role of probiotics in atopic dermatitis treatment. Read my comments below, and the stories for further insights! Read my takeaways and the full stories below.
— Joe Gorelick
 
CLINICAL CONSIDERATIONS
 
Pediatric dermatology updates
Do you use biologics in your pediatric psoriasis population? If not, you may want to brush up on two biologic agents that now carry a pediatric indication. In the atopic dermatitis space, topical crisaborole is approved for ages 2 and up. Dupilumab, which is approved for ages 18 and up, is now in phase 2 trials for kids 12-17.
Read more to familiarize yourself with these and other updates in pediatric dermatology.
 
Less isotretinoin monitoring?
Retinoid irritation is a common condition that we discuss with acne and cosmetic patients daily. In spite of There continues to be wide variability on the type of systems to monitor and the duration for which we follow these values. The survey results reported in this article suggest that monthly laboratory monitoring for lipids, LFTs, and CBCs do not improve the safety profile. In the absence of baseline abnormalities or medical history signals, the recommendation is that you consider discontinuation of monitoring after one to two months.
Learn more.
 
Probiotics may improve pediatric AD symptoms
Do you recommend probiotics to your patients with atopic dermatitis? If so, what is your specific recommendation? Many parents of acne patients ask if probiotics would be helpful in combination with an oral antibiotic, but this is not a frequent question from our atopic dermatitis population. This article provides an excellent review of the role of probiotics and offers specific recommendations that may improve symptoms for pediatric patients with atopic dermatitis.
Learn more.
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.